Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Ketamine and lidocaine infusion for refractory chronic migraine: Comparative Study
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Ketamine | Experimental | will receive ketamine |
|
| Lidocaine | Experimental | will receive lidocaine |
|
| Dextrose | Placebo Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Ketamine infusion | Drug | group A will receive ketamine intravenous infusion |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in pain scale using Numeric rating scale | Pain assessment by using a Numeric rating scale (0 (no pain) to 10 (worst possible pain). Scores of 1-3 are considered mild, 4-6 moderate, and 7-10 severe) before the infusion and daily for 1-week post infusion, then weekly for 6 weeks post infusion | From enrollment to the end of treatment at 6 weeks |
| Changes in pain scale using Migraine disability assessment | Migraine disability assessment test before the infusion and daily for 1-week post infusion, then weekly for 6 weeks post infusion | From enrollment to the end of treatment at 6 weeks |
Not provided
Not provided
Inclusion Criteria:
All participants must fulfill the following inclusion criteria
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| AbdElRahman Mohamed Mohamed | Contact | +201066586931 | hmdmhmmdl1692@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Nageh Fouly Kamel, PhD. | Assiut University | Study Chair |
| Mohamed Ahmed Abdelhameed, PhD. | Assiut University | Study Chair |
Not provided
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 18484982 | Background | Schulman EA, Lake AE 3rd, Goadsby PJ, Peterlin BL, Siegel SE, Markley HG, Lipton RB. Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society. Headache. 2008 Jun;48(6):778-82. doi: 10.1111/j.1526-4610.2008.01132.x. Epub 2008 May 14. | |
| 35356451 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D005947 | Glucose |
| D014867 | Water |
| ID | Term |
|---|---|
| D006601 | Hexoses |
| D009005 | Monosaccharides |
| D000073893 | Sugars |
| D002241 | Carbohydrates |
| D006878 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Lidocaine Intravenous Infusion |
| Drug |
group B will receive lidocaine intravenous infusion |
|
| Dextrose 5% in water | Drug | group C will only receive Dextrose 5% in water |
|
| Ray JC, Cheng S, Tsan K, Hussain H, Stark RJ, Matharu MS, Hutton E. Intravenous Lidocaine and Ketamine Infusions for Headache Disorders: A Retrospective Cohort Study. Front Neurol. 2022 Mar 9;13:842082. doi: 10.3389/fneur.2022.842082. eCollection 2022. |
| 19378524 | Background | Lauretti GR. Mechanisms of analgesia of intravenous lidocaine. Rev Bras Anestesiol. 2008 May-Jun;58(3):280-6. doi: 10.1590/s0034-70942008000300011. English, Portuguese. |
| 9806706 | Background | Kohrs R, Durieux ME. Ketamine: teaching an old drug new tricks. Anesth Analg. 1998 Nov;87(5):1186-93. doi: 10.1097/00000539-199811000-00039. No abstract available. |
| 19614702 | Background | Natoli JL, Manack A, Dean B, Butler Q, Turkel CC, Stovner L, Lipton RB. Global prevalence of chronic migraine: a systematic review. Cephalalgia. 2010 May;30(5):599-609. doi: 10.1111/j.1468-2982.2009.01941.x. |
| Hydroxides |
| D000468 | Alkalies |
| D007287 | Inorganic Chemicals |
| D000838 | Anions |
| D007477 | Ions |
| D004573 | Electrolytes |
| D010087 | Oxides |
| D017601 | Oxygen Compounds |